Organon Pharma Indonesia Tbk. vs Surya Toto Indonesia Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Surya Toto Indonesia Tbk. trades at Rp242 (market cap 2.48T, 1.32M 24h volume). The key difference: Surya Toto Indonesia Tbk. is far larger — about 23.8× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | TOTO | |
|---|---|---|
Market Cap | 104.4B | 2.48T |
Volume | — | 1.32M |
Lot | — | 13.19K |
Turnover | — | 318.92M |
Average Price | — | 241.79 |
Value | — | 318.92M |
Indicative Equilibrium Price | — | 242 |
Indicative Equilibrium Volume | — | 35 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT. Surya Toto Indonesia Tbk (the Company) was established on July 11, 1977 as a joint venture between three Indonesian company, PT Intimitra Sejahtera, PT Suryaparamitra Abadi and PT Multifortuna Asindo, and two Japanese companies, Toto Ltd., and Kashima Trading Company Ltd.
Read more on TOTO →